The University of Chicago Header Logo

Phase I safety study of ranolazine in pulmonary arterial hypertension.

Phase I safety study of ranolazine in pulmonary arterial hypertension. Pulm Circ. 2015 Dec; 5(4):691-700.

View in: PubMed